Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Speech, Linguistic and Acoustic Markers in Parkinson's Disease
A completed study evaluated speech, linguistic, and acoustic markers in Parkinson disease with mild cognitive impairment; results have been …
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Effect of Exercise, Endocannabinoids and Ketones on Cerebral Metabolism in a Cognitive Disorders Population [NA]
A completed clinical trial studied the effects of exercise, endocannabinoids, and ketones on cerebral metabolism in individuals with cogniti…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Amped-PD: Amplifying Physical Activity Through Music in Parkinson Disease [NA]
Update on the Amped-PD trial evaluating a music-based intervention to increase physical activity in Parkinson disease; the study is complete…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA® [Phase 1]
A Phase 1 pilot bioavailability study has been completed. It compares levodopa delivered via the Levodopa Cyclops device to INBRIJA (levodop…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: The GBA Multimodal Study in Parkinson's Disease
The GBA Multimodal Study in Parkinson's Disease is an ongoing clinical trial investigating GBA gene mutations in Parkinson's disease and is …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Monocentric, Prospective Study to Assess the Pharmacokinetic Profile of Continuous and Diurnal Subcutaneous Apomorphine Infusion in Patients With Parkinson's Disease [Phase 4]
This Phase 4 study evaluated the pharmacokinetic profile of continuous and diurnal subcutaneous apomorphine infusions in Parkinson's disease…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156 [Phase 1]
Phase 1 study reporting mass balance recovery and metabolite identification for the carbon-14 labeled compound BIA 28-6156 in participants w…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease [NA]
This document reports on a terminated clinical trial evaluating burst-type deep brain stimulation of the subthalamic nucleus for Parkinson d…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease [NA]
Completed clinical trial evaluating the molecular mediators of physical exercise and carnosine-induced effects in preclinical and early-stag…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Spinal Cord sTimulation thEraPy for Parkinson's Disease Patients With Gait Problems [NA]
A completed clinical trial studied spinal cord stimulation therapy to help gait problems in Parkinson disease patients.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Deep Brain Stimulation for Patients With Parkinson's Disease.
A clinical trial evaluating deep brain stimulation for Parkinson disease has completed, sponsored by INSERM in France.
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations [Phase 3]
Phase 3 trial evaluating efficacy, safety and tolerability of ND0612 versus immediate-release Levodopa/Carbidopa in Parkinson's disease pati…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Photobiomodulation and Parkinson [NA]
This entry reports a completed clinical trial investigating photobiomodulation (low-level light therapy) for Parkinson disease conducted by …
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Investigating Central Neurophysiologic Correlates of Non-Motor Symptoms of Parkinson's Disease [NA]
Completed clinical trial from the University of North Carolina investigated central neurophysiologic correlates of non-motor symptoms in Par…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19
A clinical trial evaluating chest mobility, strength, physical activity, and quality of life in Parkinson's disease patients after COVID-19.…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Parkinson and the Males Body Composition
A University of Oviedo-sponsored clinical trial related to Parkinson's disease and male body composition has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Impact of Switching to Continuous Release Dopamine Agonists [Phase 3]
Phase 3 trial evaluating outcomes after switching Parkinson's disease patients to a continuous-release dopamine agonist. Results have been p…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Relative Bioavailability Study of HRG2010 in Healthy Subjects [Phase 1]
HRG2010 underwent a Phase 1 relative bioavailability study in healthy subjects, sponsored by Jiangsu HengRui Medicine Co., Ltd. The study is…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A General Anesthesia Regimen for DBS Surgery in Patients With PD [NA]
This clinical trial update reports the completion of a study evaluating a general anesthesia regimen for deep brain stimulation surgery in P…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit [NA]
A completed clinical trial update on the Optimizing BCI-FIT toolkit (Brain Computer Interface - Functional Implementation Toolkit) sponsored…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Mobility in Atypical Parkinsonism: a Trial of Physiotherapy [NA]
This clinical trial update notes the completion of a physiotherapy-based mobility trial in individuals with atypical parkinsonism, including…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: STEM-Parkinson's Disease [NA]
The STEM-Parkinson's Disease clinical trial sponsored by Scion NeuroStim has completed and posted results on 2025-05-13; the snippet provide…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Effects of Bilateral GPI DBS on Freezing of Gait in PD
A completed clinical trial assessed the effects of bilateral Globus Pallidus Internus deep brain stimulation on freezing of gait in Parkinso…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease [Phase 1]
Phase 1 study assessing safety, tolerability, pharmacokinetics, and pharmacodynamics of GT-02287 in Parkinson's disease, with participant re…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease [NA]
A pilot study of a non-invasive neuromodulation device for Parkinson's disease was terminated, and results have been posted.